Page 46 - Alkermes News Today

We are facing new infectious disease threats — from the currently rampant respiratory syncytial virus that is sweeping through schools nationwide to the Ebola outbreak in East Africa that’s keeping

/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that its Chief Executive Officer, Richard Pops, will provide a corporate overview and update at the...

NORTHAMPTON, MA / ACCESSWIRE / December 28, 2022 / Our employees are the foundation upon which our business is built. Their expertise, intelligence and creativity drive our innovation, and their passion

/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that its Chief Executive Officer, Richard Pops, will provide a corporate overview and update at the...

DUBLIN, Dec. 28, 2022 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that its Chief Executive Officer, Richard Pops, will provide a corporate overview and update at the 41st Annual

(BPT) - Sponsored by Alkermes, Inc.

/PRNewswire/ -- The "Prefilled Syringes Market by Therapeutic Area, Type of Syringe, Type of Material, Type of Molecule, and Key Geographical Regions: Industry...

NORTHAMPTON, MA / ACCESSWIRE / December 22, 2022 / At Alkermes, our goal is to conduct our business activities in a manner that:Protects the health and safety of our employees;Minimizes the environmental

/PRNewswire/ -- The "Cytotoxic Drugs and HPAPI Manufacturing Market by Type of Product, Company Size, Scale of Operation, Type of Molecule, Type of Highly...

The opioid epidemic is rooted in overlapping mental health challenges, marginal access to effective pain control, poorly understood genetic risks, unlimited exposure to opioids in the globalized (and prohibition-model) economy, and dozens of other contributing factors.